Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.42 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17570759 | 0.77 | KCNMA1 (0.61) | RAB9AATMALDH1A1KDM4EKMT2A | |
| SCHEMBL6067788 | 0.73 | KCNMA1 (0.53) | RAB9AATMALDH1A1KDM4EKMT2A | |
| SCHEMBL16796215 | 0.72 | RAB9A (0.68) | RAB9AATMALDH1A1KDM4EKMT2A | |
| SCHEMBL3163648 | 0.71 | ALDH1A1 (0.61) | RAB9AALDH1A1KMT2ALMNAGAA | |
| SCHEMBL25951422 | 0.71 | ALDH1A1 (0.47) | RAB9AATMALDH1A1KDM4EKMT2A | |
| SCHEMBL24743260 | 0.71 | RAB9A (0.57) | RAB9AATMALDH1A1KDM4EKMT2A | |
| SCHEMBL27447734 | 0.70 | SMN1; SMN2 (0.48) | RAB9AATMALDH1A1KDM4EKMT2A | |
| SCHEMBL23936583 | 0.70 | KCNMA1 (0.51) | RAB9AATMALDH1A1KDM4EKMT2A | |
| SCHEMBL12204536 | 0.69 | SMN1; SMN2 (0.54) | RAB9AATMALDH1A1KDM4EKMT2A | |
| SCHEMBL678640 | 0.69 | RAB9A (1.00) | RAB9AATMALDH1A1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11905252-B2 | Compounds | INFLAZOME LIMITED (IE) | 2024-02-20 | — | — | US | disclosed |
| US-20210347737-A1 | NOVEL COMPOUNDS | INFLAZOME LIMITED (IE) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11905252-B2 | Compounds | NLRP3, NOD1, PYCARD | RAB9A 3000/4885ATM 4450/4885ALDH1A1 559/4885 |
| US-20210347737-A1 | NOVEL COMPOUNDS | NOD1, NLRP3, NOD2 | RAB9A 3156/4885ATM 4360/4885ALDH1A1 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.